{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:34:19Z","timestamp":1792683259150,"version":"4.5.0"},"reference-count":67,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"10","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["da044311"],"award-info":[{"award-number":["da044311"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["da032681"],"award-info":[{"award-number":["da032681"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["da031747"],"award-info":[{"award-number":["da031747"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["da041513"],"award-info":[{"award-number":["da041513"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["da016176"],"award-info":[{"award-number":["da016176"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001797","name":"PhRMA Foundation","doi-asserted-by":"crossref","award":["Research Starter Grant"],"award-info":[{"award-number":["Research Starter Grant"]}],"id":[{"id":"10.13039\/100001797","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Adv."],"published-print":{"date-parts":[[2019,10,11]]},"abstract":"<jats:p>Nearly 80% of smokers attempting to quit fail, but research on microglia may open a new avenue for smoking cessation drugs.<\/jats:p>","DOI":"10.1126\/sciadv.aax7031","type":"journal-article","created":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T19:25:47Z","timestamp":1570649147000},"source":"Crossref","is-referenced-by-count":104,"title":["Microglia morphology and proinflammatory signaling in the nucleus accumbens during nicotine withdrawal"],"prefix":"10.1126","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2569-0955","authenticated-orcid":true,"given":"Adewale","family":"Adeluyi","sequence":"first","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Guerin","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5279-459X","authenticated-orcid":true,"given":"Miranda L.","family":"Fisher","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC, USA."},{"name":"Department of Pharmaceutical Sciences, University of Kentucky College of Pharmacy, Lexington, KY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4956-3595","authenticated-orcid":true,"given":"Ashley","family":"Galloway","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Physiology, and Neuroscience, University of South Carolina School of Medicine, Columbia, SC, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Cole","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Physiology, and Neuroscience, University of South Carolina School of Medicine, Columbia, SC, USA."},{"name":"Department of Neuroscience, University of Kentucky School of Medicine, Lexington, KY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherine S. L.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, SC, USA."},{"name":"Neuroene Therapeutics, Mt Pleasant, SC, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1815-9565","authenticated-orcid":true,"given":"Michael D.","family":"Wyatt","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7354-5691","authenticated-orcid":true,"given":"Shannon W.","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Biology, Furman University, Greenville, SC, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5507-8903","authenticated-orcid":true,"given":"Linnea R.","family":"Freeman","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of South Carolina, Columbia, SC, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel I.","family":"Ortinski","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Physiology, and Neuroscience, University of South Carolina School of Medicine, Columbia, SC, USA."},{"name":"Department of Neuroscience, University of Kentucky School of Medicine, Lexington, KY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7258-1639","authenticated-orcid":true,"given":"Jill R.","family":"Turner","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC, USA."},{"name":"Department of Pharmaceutical Sciences, University of Kentucky College of Pharmacy, Lexington, KY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.thorsurg.2013.01.009","article-title":"Tobacco smoking: The leading cause of preventable disease worldwide","volume":"23","author":"Samet J. M.","year":"2013","unstructured":"J. M. Samet, Tobacco smoking: The leading cause of preventable disease worldwide. Thorac. Surg. Clin. 23, 103\u2013112 (2013).","journal-title":"Thorac. Surg. Clin."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/0960327113493306","article-title":"The detox strategy in smoking comprising nutraceutical formulas of non-hydrolyzed carnosine or carcinine used to protect human health","volume":"33","author":"Babizhayev M. A.","year":"2013","unstructured":"M. A. Babizhayev, The detox strategy in smoking comprising nutraceutical formulas of non-hydrolyzed carnosine or carcinine used to protect human health. Hum. Exp. Toxicol. 33, 284\u2013316 (2013).","journal-title":"Hum. Exp. Toxicol."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.tips.2010.12.008","article-title":"Treatment of nicotine addiction: Present therapeutic options and pipeline developments","volume":"32","author":"Polosa R.","year":"2011","unstructured":"R. Polosa, N. L. Benowitz, Treatment of nicotine addiction: Present therapeutic options and pipeline developments. Trends Pharmacol. Sci. 32, 281\u2013289 (2011).","journal-title":"Trends Pharmacol. Sci."},{"key":"e_1_3_2_5_2","unstructured":"World Health Organization WHO Global Report: Mortality Attributable to Tobacco. Geneva Switzerland (2012); http:\/\/apps.who.int\/iris\/bitstream\/10665\/44815\/1\/9789241564434_eng.pdf."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1021\/jm050069n","article-title":"Varenicline: An \u03b14\u03b22 nicotinic receptor partial agonist for smoking cessation","volume":"48","author":"Coe J. W.","year":"2005","unstructured":"J. W. Coe, P. R. Brooks, M. G. Vetelino, M. C. Wirtz, E. P. Arnold, J. Huang, S. B. Sands, T. I. Davis, L. A. Lebel, C. B. Fox, A. Shrikhande, J. H. Heym, E. Schaeffer, H. Rollema, Y. Lu, R. S. Mansbach, L. K. Chambers, C. C. Rovetti, D. W. Schulz, F. D. Tingley, B. T. O\u2019Neill, Varenicline: An \u03b14\u03b22 nicotinic receptor partial agonist for smoking cessation. J. Med. Chem. 48, 3474\u20133477 (2005).","journal-title":"J. Med. Chem."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.neuropharm.2006.10.016","article-title":"Pharmacological profile of the \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid","volume":"52","author":"Rollema H.","year":"2007","unstructured":"H. Rollema, L. K. Chambers, J. W. Coe, J. Glowa, R. S. Hurst, L. A. Lebel, Y. Lu, R. S. Mansbach, R. J. Mather, C. C. Rovetti, S. B. Sands, E. Schaeffer, D. W. Schulz, F. D. Tingley III, K. E. Williams, Pharmacological profile of the \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 52, 985\u2013994 (2007).","journal-title":"Neuropharmacology"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1124\/mol.106.027318","article-title":"Sazetidine-A, a novel ligand that desensitizes \u03b14\u03b22 nicotinic acetylcholine receptors without activating them","volume":"70","author":"Xiao Y.","year":"2006","unstructured":"Y. Xiao, H. Fan, J. L. Musachio, Z.-L. Wei, S. K. Chellappan, A. P. Kozikowski, K. J. Kellar, Sazetidine-A, a novel ligand that desensitizes \u03b14\u03b22 nicotinic acetylcholine receptors without activating them. Mol. Pharmacol. 70, 1454\u20131460 (2006).","journal-title":"Mol. Pharmacol."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4397"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"12540","DOI":"10.1038\/ncomms12540","article-title":"Microglia contact induces synapse formation in developing somatosensory cortex","volume":"7","author":"Miyamoto A.","year":"2016","unstructured":"A. Miyamoto, H. Wake, A. W. Ishikawa, K. Eto, K. Shibata, H. Murakoshi, S. Koizumi, A. J. Moorhouse, Y. Yoshimura, J. Nabekura, Microglia contact induces synapse formation in developing somatosensory cortex. Nat. Commun. 7, 12540 (2016).","journal-title":"Nat. Commun."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03566-5"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2015.09.001"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.nlm.2011.02.014","article-title":"Aberrant learning and memory in addiction","volume":"96","author":"Torregrossa M. M.","year":"2011","unstructured":"M. M. Torregrossa, P. R. Corlett, J. R. Taylor, Aberrant learning and memory in addiction. Neurobiol. Learn. Mem. 96, 609\u2013623 (2011).","journal-title":"Neurobiol. Learn. Mem."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1101\/lm.042192.116","article-title":"Effects of drugs of abuse on hippocampal plasticity and hippocampus-dependent learning and memory: Contributions to development and maintenance of addiction","volume":"23","author":"Kutlu M. G.","year":"2016","unstructured":"M. G. Kutlu, T. J. Gould, Effects of drugs of abuse on hippocampal plasticity and hippocampus-dependent learning and memory: Contributions to development and maintenance of addiction. Learn. Mem. 23, 515\u2013533 (2016).","journal-title":"Learn. Mem."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurt.2010.05.014"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2014.03.034"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"9690","DOI":"10.1523\/JNEUROSCI.0794-12.2012","article-title":"NADPH oxidase mediates depressive behavior induced by chronic stress in mice","volume":"32","author":"Seo J.-S.","year":"2012","unstructured":"J.-S. Seo, J.-Y. Park, J. Choi, T.-K. Kim, J.-H. Shin, J.-K. Lee, P.-L. Han, NADPH oxidase mediates depressive behavior induced by chronic stress in mice. J. Neurosci. 32, 9690\u20139699 (2012).","journal-title":"J. Neurosci."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"13234","DOI":"10.1038\/ncomms13234","article-title":"Promotion of behavior and neuronal function by reactive oxygen species in C. elegans","volume":"7","author":"Li G.","year":"2016","unstructured":"G. Li, J. Gong, H. Lei, J. Liu, X. Z. S. Xu, Promotion of behavior and neuronal function by reactive oxygen species in C. elegans. Nat. Commun. 7, 13234 (2016).","journal-title":"Nat. Commun."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.nucmedbio.2011.02.016","article-title":"Evaluation of striatal oxidative stress in patients with Parkinson\u2019s disease using [62Cu]ATSM PET","volume":"38","author":"Ikawa M.","year":"2011","unstructured":"M. Ikawa, H. Okazawa, T. Kudo, M. Kuriyama, Y. Fujibayashi, M. Yoneda, Evaluation of striatal oxidative stress in patients with Parkinson\u2019s disease using [62Cu]ATSM PET. Nucl. Med. Biol. 38, 945\u2013951 (2011).","journal-title":"Nucl. Med. Biol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.neuroscience.2015.06.033","article-title":"The ins and outs of the striatum: Role in drug addiction","volume":"301","author":"Yager L. M.","year":"2015","unstructured":"L. M. Yager, A. F. Garcia, A. M. Wunsch, S. M. Ferguson, The ins and outs of the striatum: Role in drug addiction. Neuroscience 301, 529\u2013541 (2015).","journal-title":"Neuroscience"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2013.104","article-title":"Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence","volume":"19","author":"Turner J. R.","year":"2014","unstructured":"J. R. Turner, R. Ray, B. Lee, L. Everett, J. Xiang, C. Jepson, K. H. Kaestner, C. Lerman, J. A. Blendy, Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence. Mol. Psychiatry 19, 801\u2013810 (2014).","journal-title":"Mol. Psychiatry"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/npp.2016.257","article-title":"Distinct roles of CREB within the ventral and dorsal hippocampus in mediating nicotine withdrawal phenotypes","volume":"42","author":"Fisher M. L.","year":"2017","unstructured":"M. L. Fisher, R. M. LeMalefant, L. Zhou, G. Huang, J. R. Turner, Distinct roles of CREB within the ventral and dorsal hippocampus in mediating nicotine withdrawal phenotypes. Neuropsychopharmacology 42, 1599\u20131609 (2017).","journal-title":"Neuropsychopharmacology"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbr.2008.05.018","article-title":"Anxiety-like behavior during nicotine withdrawal predict subsequent nicotine consumption in adolescent C57BL\/6 mice","volume":"193","author":"Manh\u00e3es A. C.","year":"2008","unstructured":"A. C. Manh\u00e3es, M. C. Guthierrez, C. C. Filgueiras, Y. Abreu-Villa\u00e7a, Anxiety-like behavior during nicotine withdrawal predict subsequent nicotine consumption in adolescent C57BL\/6 mice. Behav. Brain Res. 193, 216\u2013224 (2008).","journal-title":"Behav. Brain Res."},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1360-0443.2010.03173.x","article-title":"Anxiety diagnoses in smokers seeking cessation treatment: Relations with tobacco dependence, withdrawal, outcome and response to treatment outcome and response to treatment","volume":"106","author":"Piper M. E.","year":"2011","unstructured":"M. E. Piper, J. W. Cook, T. R. Schlam, D. E. Jorenby, T. B. Baker, Anxiety diagnoses in smokers seeking cessation treatment: Relations with tobacco dependence, withdrawal, outcome and response to treatment outcome and response to treatment. Addiction 106, 418\u2013427 (2011).","journal-title":"Addiction"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2012.04.059"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3381"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.bbr.2009.12.039","article-title":"Moderate treadmill exercise prevents oxidative stress-induced anxiety-like behavior in rats","volume":"208","author":"Salim S.","year":"2010","unstructured":"S. Salim, N. Sarraj, M. Taneja, K. Saha, M. V. Tejada-Simon, G.Chugh, Moderate treadmill exercise prevents oxidative stress-induced anxiety-like behavior in rats. Behav. Brain Res. 208, 545\u2013552 (2010).","journal-title":"Behav. Brain Res."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.brainres.2013.09.033","article-title":"Depression, anxiety-like behavior and memory impairment are associated with increased oxidative stress and inflammation in a rat model of social stress","volume":"1539","author":"Patki G.","year":"2013","unstructured":"G. Patki, N. Solanki, F. Atrooz, F. Allam, S. Salim, Depression, anxiety-like behavior and memory impairment are associated with increased oxidative stress and inflammation in a rat model of social stress. Brain Res. 1539, 73\u201386 (2013).","journal-title":"Brain Res."},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nan.12011","article-title":"Review: Activation patterns of microglia and their identification in the human brain","volume":"39","author":"Boche D.","year":"2013","unstructured":"D. Boche, V. H. Perry, J. A. R. Nicoll, Review: Activation patterns of microglia and their identification in the human brain. Neuropathol. Appl. Neurobiol. 39, 3\u201318 (2013).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-016-3578-5"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/ars.2009.2887","article-title":"Protein carbonylation","volume":"12","author":"Suzuki Y. J.","year":"2010","unstructured":"Y. J. Suzuki, M. Carini, D. A. Butterfield, Protein carbonylation. Antioxid. Redox Signal 12, 323\u2013325 (2010).","journal-title":"Antioxid. Redox Signal"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btx441"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/ndt\/gfm077","article-title":"Novel sources of reactive oxygen species in the human body","volume":"22","author":"Orient A.","year":"2007","unstructured":"A. Orient, A. Donk\u00f3, A. Szab\u00f3, T. L. Leto, M. Geiszt, Novel sources of reactive oxygen species in the human body. Nephrol. Dial. Transplant. 22, 1281\u20131288 (2007).","journal-title":"Nephrol. Dial. Transplant."},{"key":"e_1_3_2_34_2","first-page":"301","article-title":"NOX activation by subunit interaction and underlying mechanisms in disease","volume":"10","author":"Rastogi R.","year":"2016","unstructured":"R. Rastogi, X. Geng, F. Li, Y. Ding, NOX activation by subunit interaction and underlying mechanisms in disease. Front. Cell. Neurosci. 10, 301 (2016).","journal-title":"Front. Cell. Neurosci."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2015.12.002"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2007.04.021"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"e1000864","DOI":"10.1371\/journal.ppat.1000864","article-title":"The type I NADH dehydrogenase of Mycobacterium tuberculosis counters phagosomal NOX2 activity to inhibit TNF-\u03b1-mediated host cell apoptosis","volume":"6","author":"Miller J. L.","year":"2010","unstructured":"J. L. Miller, K. Velmurugan, M. J. Cowan, V. Briken, The type I NADH dehydrogenase of Mycobacterium tuberculosis counters phagosomal NOX2 activity to inhibit TNF-\u03b1-mediated host cell apoptosis. PLOS Pathog. 6, e1000864 (2010).","journal-title":"PLOS Pathog."},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.tips.2016.02.008","article-title":"TSPO finds NOX2 in microglia for redox homeostasis","volume":"37","author":"Guilarte T. R.","year":"2016","unstructured":"T. R. Guilarte, M. K. Loth, S. R. Guariglia, TSPO finds NOX2 in microglia for redox homeostasis. Trends Pharmacol. Sci. 37, 334\u2013343 (2016).","journal-title":"Trends Pharmacol. Sci."},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1089\/ars.2013.5703","article-title":"New insights on NOX enzymes in the central nervous system","volume":"20","author":"Nayernia Z.","year":"2014","unstructured":"Z. Nayernia, V. Jaquet, K.-H. Krause, New insights on NOX enzymes in the central nervous system. Antioxid. Redox Signal 20, 2815\u20132837 (2014).","journal-title":"Antioxid. Redox Signal"},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jneuroim.2010.05.015","article-title":"Tickets to the brain: Role of CCR2 and CX3CR1 in myeloid cell entry in the CNS","volume":"224","author":"Prinz M.","year":"2010","unstructured":"M. Prinz, J. Priller, Tickets to the brain: Role of CCR2 and CX3CR1 in myeloid cell entry in the CNS. J. Neuroimmunol. 224, 80\u201384 (2010).","journal-title":"J. Neuroimmunol."},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4049\/jimmunol.1100421","article-title":"The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood","volume":"188","author":"Mizutani M.","year":"2011","unstructured":"M. Mizutani, P. A. Pino, N. Saederup, I. F. Charo, R. M. Ransohoff, A. E. Cardona, The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood. J. Immunol. 188, 29\u201336 (2011).","journal-title":"J. Immunol."},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/npp.2017.48","article-title":"Effect of cigarette smoking on a marker for neuroinflammation: A [11C]DAA1106 positron emission tomography study","volume":"42","author":"Brody A. L.","year":"2017","unstructured":"A. L. Brody, R. Hubert, R. Enoki, L. Y. Garcia, M. S. Mamoun, K. Okita, E. D. London, E. L. Nurmi, L. C. Seaman, M. A. Mandelkern, Effect of cigarette smoking on a marker for neuroinflammation: A [11C]DAA1106 positron emission tomography study. Neuropsychopharmacology 42, 1630\u20131639 (2017).","journal-title":"Neuropsychopharmacology"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2017.06.020"},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12576-016-0460-5","article-title":"Nicotine inhibits activation of microglial proton currents via interactions with \u03b17 acetylcholine receptors","volume":"67","author":"Noda M.","year":"2017","unstructured":"M. Noda, A. I. Kobayashi, Nicotine inhibits activation of microglial proton currents via interactions with \u03b17 acetylcholine receptors. J. Physiol. Sci. 67, 235\u2013245 (2017).","journal-title":"J. Physiol. Sci."},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1468-1331.2007.01949.x","article-title":"Chronic high dose transdermal nicotine in Parkinson\u2019s disease: An open trial","volume":"14","author":"Villafane G.","year":"2007","unstructured":"G. Villafane, P. Cesaro, A. Rialland, S. Baloul, S. Azimi, C. Bourdet, J. le Houezec, I. Macquin-Mavier, P. Maison, Chronic high dose transdermal nicotine in Parkinson\u2019s disease: An open trial. Eur. J. Neurol. 14, 1313\u20131316 (2007).","journal-title":"Eur. J. Neurol."},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1212\/WNL.0b013e31823efcbb","article-title":"Nicotine treatment of mild cognitive impairment: A 6-month double-blind pilot clinical trial","volume":"78","author":"Newhouse P.","year":"2012","unstructured":"P. Newhouse, K. Kellar, P. Aisen, H. White, K. Wesnes, E. Coderre, A. Pfaff, H. Wilkins, D. Howard, E. D. Levin, Nicotine treatment of mild cognitive impairment: A 6-month double-blind pilot clinical trial. Neurology 78, 91\u2013101 (2012).","journal-title":"Neurology"},{"key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMra0809890","article-title":"Nicotine addiction","volume":"362","author":"Benowitz N. L.","year":"2010","unstructured":"N. L. Benowitz, Nicotine addiction. N. Engl. J. Med. 362, 2295\u20132303 (2010).","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pbb.2015.12.010","article-title":"A novel method to induce nicotine dependence by intermittent drug delivery using osmotic minipumps","volume":"142","author":"Brynildsen J. K.","year":"2016","unstructured":"J. K. Brynildsen, J. Najar, L.-M. Hsu, D. B. Vaupel, H. Lu, T. J. Ross, Y. Yang, E. A. Stein, A novel method to induce nicotine dependence by intermittent drug delivery using osmotic minipumps. Pharmacol. Biochem. Behav. 142, 79\u201384 (2016).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pbb.2018.06.002","article-title":"Differential effects of withdrawal from intermittent and continuous nicotine exposure on reward deficit and somatic aspects of nicotine withdrawal and expression of \u03b14\u03b22* nAChRs in Wistar male rats","volume":"171","author":"Semenova S.","year":"2018","unstructured":"S. Semenova, X. Jin, T. D. McClure-Begley, M. P. Tadman, M. J. Marks, A. Markou, Differential effects of withdrawal from intermittent and continuous nicotine exposure on reward deficit and somatic aspects of nicotine withdrawal and expression of \u03b14\u03b22* nAChRs in Wistar male rats. Pharmacol. Biochem. Behav. 171, 54\u201365 (2018).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"e_1_3_2_50_2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.neuron.2016.03.030","article-title":"Microglial TNF-\u03b1 suppresses cocaine-induced plasticity and behavioral sensitization","volume":"90","author":"Lewitus G. M.","year":"2016","unstructured":"G. M. Lewitus, S. C. Konefal, A. D. Greenhalgh, H. Pribiag, K. Augereau, D. Stellwagen, Microglial TNF-\u03b1 suppresses cocaine-induced plasticity and behavioral sensitization. Neuron 90, 483\u2013491 (2016).","journal-title":"Neuron"},{"key":"e_1_3_2_51_2","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1523\/JNEUROSCI.2516-12.2013","article-title":"Adolescent morphine exposure affects long-term microglial function and later-life relapse liability in a model of addiction","volume":"33","author":"Schwarz J. M.","year":"2013","unstructured":"J. M. Schwarz, S. D. Bilbo, Adolescent morphine exposure affects long-term microglial function and later-life relapse liability in a model of addiction. J. Neurosci. 33, 961\u2013971 (2013).","journal-title":"J. Neurosci."},{"key":"e_1_3_2_52_2","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/dneu.22569","article-title":"Microglia: Driving critical periods and sexual differentiation of the brain","volume":"78","author":"VanRyzin J. W.","year":"2018","unstructured":"J. W. VanRyzin, L. A. Pickett, M. M. McCarthy, Microglia: Driving critical periods and sexual differentiation of the brain. Dev. Neurobiol. 78, 580\u2013592 (2018).","journal-title":"Dev. Neurobiol."},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2014.89"},{"key":"e_1_3_2_54_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13024-017-0150-7","article-title":"NADPH oxidase in brain injury and neurodegenerative disorders","volume":"12","author":"Ma M. W.","year":"2017","unstructured":"M. W. Ma, J. Wang, Q. Zhang, R. Wang, K. M. Dhandapani, R. K. Vadlamudi, D. W. Brann, NADPH oxidase in brain injury and neurodegenerative disorders. Mol. Neurodegener. 12, 7 (2017).","journal-title":"Mol. Neurodegener."},{"key":"e_1_3_2_55_2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2202-12-49","article-title":"Dexamethasone inhibits the Nox-dependent ROS production via suppression of MKP-1-dependent MAPK pathways in activated microglia","volume":"12","author":"Huo Y.","year":"2011","unstructured":"Y. Huo, P. Rangarajan, E. A. Ling, S. T. Dheen, Dexamethasone inhibits the Nox-dependent ROS production via suppression of MKP-1-dependent MAPK pathways in activated microglia. BMC Neurosci. 12, 49 (2011).","journal-title":"BMC Neurosci."},{"key":"e_1_3_2_56_2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fnbeh.2017.00207","article-title":"Microglial over-activation by social defeat stress contributes to anxiety- and depressive-like behaviors","volume":"11","author":"Stein D. J.","year":"2017","unstructured":"D. J. Stein, M. F. Vasconcelos, L. Albrechet-Souza, K. M. M. Ceres\u00e9r, R. M. M. de Almeida, Microglial over-activation by social defeat stress contributes to anxiety- and depressive-like behaviors. Front. Behav. Neurosci. 11, 207 (2017).","journal-title":"Front. Behav. Neurosci."},{"key":"e_1_3_2_57_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12974-018-1054-3","article-title":"Microglial activation mediates chronic mild stress-induced depressive- and anxiety-like behavior in adult rats","volume":"15","author":"Wang Y.-L.","year":"2018","unstructured":"Y.-L. Wang, Q.-Q. Han, W.-Q. Gong, D.-H. Pan, L.-Z. Wang, W. Hu, M. Yang, B. Li, J. Yu, Q. Liu, Microglial activation mediates chronic mild stress-induced depressive- and anxiety-like behavior in adult rats. J. Neuroinflammation 15, 21 (2018).","journal-title":"J. Neuroinflammation"},{"key":"e_1_3_2_58_2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0149-7634(01)00011-2","article-title":"A detailed ethological analysis of the mouse open field test: Effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field","volume":"25","author":"Choleris E.","year":"2001","unstructured":"E. Choleris, A. W. Thomas, M. Kavaliers, F. S. Prato, A detailed ethological analysis of the mouse open field test: Effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci. Biobehav. Rev. 25, 235\u2013260 (2001).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"e_1_3_2_59_2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2006.07.015","article-title":"A combined marble burying\u2013locomotor activity test in mice: A practical screening test with sensitivity to different classes of anxiolytics and antidepressants","volume":"547","author":"Nicolas L. B.","year":"2006","unstructured":"L. B. Nicolas, Y. Kolb, E. P. Prinssen, A combined marble burying\u2013locomotor activity test in mice: A practical screening test with sensitivity to different classes of anxiolytics and antidepressants. Eur. J. Pharmacol. 547, 106\u2013115 (2006).","journal-title":"Eur. J. Pharmacol."},{"key":"e_1_3_2_60_2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.bbi.2018.11.003","article-title":"Anti-inflammatory agents for smoking cessation? Focus on cognitive deficits associated with nicotine withdrawal in male mice","volume":"75","author":"Saravia R.","year":"2019","unstructured":"R. Saravia, M. Ten-Blanco, M. T. Grande, R. Maldonado, F. Berrendero, Anti-inflammatory agents for smoking cessation? Focus on cognitive deficits associated with nicotine withdrawal in male mice. Brain Behav. Immun. 75, 228\u2013239 (2019).","journal-title":"Brain Behav. Immun."},{"key":"e_1_3_2_61_2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0163-1047(87)90752-7","article-title":"Effects of the nicotinic receptor blocker mecamylamine on radial-arm maze performance in rats","volume":"48","author":"Levin E. D.","year":"1987","unstructured":"E. D. Levin, M. Castonguay, G. D. Ellison, Effects of the nicotinic receptor blocker mecamylamine on radial-arm maze performance in rats. Behav. Neural Biol. 48, 206\u2013212 (1987).","journal-title":"Behav. Neural Biol."},{"key":"e_1_3_2_62_2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00213-004-1804-z","article-title":"Effects of nicotine and mecamylamine on cognition in rhesus monkeys","volume":"175","author":"Katner S. N.","year":"2004","unstructured":"S. N. Katner, S. A. Davis, A. J. Kirsten, M. A. Taffe, Effects of nicotine and mecamylamine on cognition in rhesus monkeys. Psychopharmacology 175, 225\u2013240 (2004).","journal-title":"Psychopharmacology"},{"key":"e_1_3_2_63_2","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/bcp.13268","article-title":"An anti-nicotinic cognitive challenge model using mecamylamine in comparison with the anti-muscarinic cognitive challenge using scopolamine","volume":"83","author":"Baakman A. C.","year":"2017","unstructured":"A. C. Baakman, R. Alvarez-Jimenez, R. Rissmann, E. S. Klaassen, J. Stevens, S. C. Goulooze, J. C. G. den Burger, E. L. Swart, J. M. A. van Gerven, G. J. Groeneveld, An anti-nicotinic cognitive challenge model using mecamylamine in comparison with the anti-muscarinic cognitive challenge using scopolamine. Br. J. Clin. Pharmacol. 83, 1676\u20131687 (2017).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"e_1_3_2_64_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.296.1.47","article-title":"Varenicline, an \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial","volume":"296","author":"Gonzales D.","year":"2006","unstructured":"D. Gonzales, S. I. Rennard, M. Nides, C. Oncken, S. Azoulay, C. B. Billing, E. J. Watsky, J. Gong, K. E. Williams, K. R. Reeves; Varenicline Phase 3 Study Group, Varenicline, an \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial. JAMA 296, 47\u201355 (2006).","journal-title":"JAMA"},{"key":"e_1_3_2_65_2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00213-006-0441-0","article-title":"Guidelines on nicotine dose selection for in vivo research","volume":"190","author":"Matta S. G.","year":"2007","unstructured":"S. G. Matta, D. J. Balfour, N. L. Benowitz, R. T. Boyd, J. J. Buccafusco, A. R. Caggiula, C. R. Craig, A. C. Collins, M. I. Damaj, E. C. Donny, P. S. Gardiner, S. R. Grady, U. Heberlein, S. S. Leonard, E. D. Levin, R. J. Lukas, A. Markou, M. J. Marks, S. E. McCallum, N. Parameswaran, K. A. Perkins, M. R. Picciotto, M. Quik, J. E. Rose, A. Rothenfluh, W. R. Schafer, I. P. Stolerman, R. F. Tyndale, J. M. Wehner, J. M. Zirger, Guidelines on nicotine dose selection for in vivo research. Psychopharmacology 190, 269\u2013319 (2007).","journal-title":"Psychopharmacology"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-017-0307-x"},{"key":"e_1_3_2_67_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00213-008-1243-3","article-title":"Endocrine and gene expression changes following forced swim stress exposure during cocaine abstinence in mice","volume":"201","author":"Cleck J. N.","year":"2008","unstructured":"J. N. Cleck, L. E. Ecke, J. A. Blendy, Endocrine and gene expression changes following forced swim stress exposure during cocaine abstinence in mice. Psychopharmacology 201, 15\u201328 (2008).","journal-title":"Psychopharmacology"},{"key":"e_1_3_2_68_2","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2013\u2206\u2206C\n                  T method","volume":"25","author":"Livak K. J.","year":"2001","unstructured":"K. J. Livak, T. D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2013\u2206\u2206CT method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"}],"container-title":["Science Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/sciadv.aax7031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T12:08:16Z","timestamp":1704802096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/sciadv.aax7031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,11]]},"references-count":67,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10,11]]}},"alternative-id":["10.1126\/sciadv.aax7031"],"URL":"https:\/\/doi.org\/10.1126\/sciadv.aax7031","relation":{},"ISSN":["2375-2548"],"issn-type":[{"value":"2375-2548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,11]]},"article-number":"eaax7031"}}